Cargando…

Tumour-infiltrating CD8(+) lymphocytes and colorectal cancer recurrence by tumour and nodal stage

BACKGROUND: Intratumoural T-cell infiltrate intensity cortes wrelaith clinical outcome in stage II/III colorectal cancer (CRC). We aimed to determine whether this association varies across this heterogeneous group. METHODS: We performed a pooled analysis of 1804 CRCs from the QUASAR2 and VICTOR tria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glaire, Mark A., Domingo, Enric, Sveen, Anita, Bruun, Jarle, Nesbakken, Arild, Nicholson, George, Novelli, Marco, Lawson, Kay, Oukrif, Dahmane, Kildal, Wanja, Danielsen, Havard E., Kerr, Rachel, Kerr, David, Tomlinson, Ian, Lothe, Ragnhild A., Church, David N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738075/ https://www.ncbi.nlm.nih.gov/pubmed/31388185 http://dx.doi.org/10.1038/s41416-019-0540-4

Ejemplares similares

Correction: Tumour-infiltrating CD8(+) lymphocytes and colorectal cancer recurrence by tumour and nodal stage
por: Glaire, Mark A., et al.
Publicado: (2019)

Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
por: Bergsland, Christian H, et al.
Publicado: (2020)

Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer
por: Bergsland, Christian H., et al.
Publicado: (2022)

Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series
por: Bruun, Jarle, et al.
Publicado: (2014)

Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer
por: Smeby, Jørgen, et al.
Publicado: (2019)

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models
por: Eide, Peter W., et al.
Publicado: (2017)

Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1
por: Sveen, Anita, et al.
Publicado: (2017)

Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity
por: Smeby, Jørgen, et al.
Publicado: (2020)

Automated assessment of CD8(+) T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer
por: Jiang, Dan, et al.
Publicado: (2021)

Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains
por: Berg, Kaja C. G., et al.
Publicado: (2019)

Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2
por: Lopes, Nair, et al.
Publicado: (2019)

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
por: Bruun, Jarle, et al.
Publicado: (2018)

Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
por: Sveen, Anita, et al.
Publicado: (2011)

Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
por: Eilertsen, Ina A., et al.
Publicado: (2018)

Phospholipase C Isozymes Are Deregulated in Colorectal Cancer – Insights Gained from Gene Set Enrichment Analysis of the Transcriptome
por: Danielsen, Stine A., et al.
Publicado: (2011)

Prognostic Classification of Early Ovarian Cancer Based on very Low Dimensionality Adaptive Texture Feature Vectors from Cell Nuclei from Monolayers and Histological Sections
por: Nielsen, Birgitte, et al.
Publicado: (2001)

Accounting for intensity variation in image analysis of large‐scale multiplexed clinical trial datasets
por: Frei, Anja L, et al.
Publicado: (2023)

Use of multivariate analysis to suggest a new molecular classification of colorectal cancer
por: Domingo, Enric, et al.
Publicado: (2013)

Tumour heterogeneity poses a significant challenge to cancer biomarker research
por: Cyll, Karolina, et al.
Publicado: (2017)

The expressed mutational landscape of microsatellite stable colorectal cancers
por: Sveen, Anita, et al.
Publicado: (2021)

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2018)

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
por: Domingo, Enric, et al.
Publicado: (2018)

Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN
por: Beggs, Andrew D, et al.
Publicado: (2012)

Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
por: Smeby, Jørgen, et al.
Publicado: (2019)

Chromatin organisation and cancer prognosis: a pan-cancer study
por: Kleppe, Andreas, et al.
Publicado: (2018)

E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
por: Bruun, Jarle, et al.
Publicado: (2021)

The Prognostic Value of Adaptive Nuclear Texture Features from Patient Gray Level Entropy Matrices in Early Stage Ovarian Cancer
por: Nielsen, Birgitte, et al.
Publicado: (2012)

Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast
por: Hasebe, T, et al.
Publicado: (2005)

Prognostic markers for colorectal cancer: estimating ploidy and stroma
por: Danielsen, H E, et al.
Publicado: (2018)

Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours
por: Pipinikas, Christodoulos P, et al.
Publicado: (2015)

Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases
por: Kryeziu, Kushtrim, et al.
Publicado: (2021)

Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast
por: Hasebe, T, et al.
Publicado: (2011)

A Tissue-Based Comparative Effectiveness Analysis of Biomarkers for Early Detection of Colorectal Tumors
por: Ahmed, Deeqa, et al.
Publicado: (2012)

Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer
por: Ersvær, Elin, et al.
Publicado: (2019)

Genomic and prognostic heterogeneity among RAS/BRAF (V600E)/TP53 co‐mutated resectable colorectal liver metastases
por: Berg, Kaja C. G., et al.
Publicado: (2021)

CMS-dependent prognostic impact of KRAS and BRAF(V600E) mutations in primary colorectal cancer
por: Smeby, J, et al.
Publicado: (2018)

Case of an Extremely Vascular Tumour Simulating Aneurism, for Which the Carotid Artery Was Tied
por: Kerr, David
Publicado: (1844)

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
por: Eide, Peter W., et al.
Publicado: (2021)

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors
por: Kolberg, Matthias, et al.
Publicado: (2017)

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies
por: Berg, Kaja C. G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vm7osdq23trb57h2v77evvsoun